Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study... by Anouk W. M. A. Schaeffers, Lot A. Devriese, Carla H. van Gils, Jan Willem Dankbaar, Jens Voortman, Jan Paul de Boer, Marije Slingerland, Mathijs P. Hendriks, Ernst J. Smid, Geert W. J. Frederix, Remco de Bree

Get full text